Positive and Negative Effects of Antipsychotic Medication: An International Online Survey of 832 Recipients
- PMID: 30827259
- PMCID: PMC6864560
- DOI: 10.2174/1574886314666190301152734
Positive and Negative Effects of Antipsychotic Medication: An International Online Survey of 832 Recipients
Abstract
Background: Antipsychotic medication is currently the treatment of choice for psychosis, but few studies directly survey the first-hand experience of recipients.
Objective: To ascertain the experiences and opinions of an international sample of users of antipsychotic drugs, regarding positive and negative effects.
Methods: An online direct-to-consumer questionnaire was completed by 832 users of antipsychotics, from 30 countries - predominantly USA, UK and Australia. This is the largest such sample to date.
Results: Over half (56%) thought, the drugs reduced the problems they were prescribed for, but 27% thought they made them worse. Slightly less people found the drugs generally 'helpful' (41%) than found them 'unhelpful' (43%). While 35% reported that their 'quality of life' was 'improved', 54% reported that it was made 'worse'. The average number of adverse effects reported was 11, with an average of five at the 'severe' level. Fourteen effects were reported by 57% or more participants, most commonly: 'Drowsiness, feeling tired, sedation' (92%), 'Loss of motivation' (86%), 'Slowed thoughts' (86%), and 'Emotional numbing' (85%). Suicidality was reported to be a side effect by 58%. Older people reported particularly poor outcomes and high levels of adverse effects. Duration of treatment was unrelated to positive outcomes but significantly related to negative outcomes. Most respondents (70%) had tried to stop taking the drugs. The most common reasons people wanted to stop were the side effects (64%) and worries about long-term physical health (52%). Most (70%) did not recall being told anything at all about side effects.
Conclusion: Clinical implications are discussed, with a particular focus on the principles of informed consent, and involving patients in decision making about their own lives.
Keywords: Antipsychotic drugs; TAE; maudsley side effects; psychosis; second generation; sedation; suicidality..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
References
-
- Hutton P., Weinmann S., Bola J., Read J. Antipsychotic drugs. In: Read J., Dillon J., editors. Models of madness: Psychological, social and biological approaches to psychosis. 2nd ed. London: Routledge; 2013. pp. 105–124.
-
- National Institute for Health and Care Excellence . Psychosis and schizophrenia in adults. Quality standard. London: NICE; 2015.
-
- American Psychiatric Association Practice guidelines for the treatment of patients with schizophrenia. 2nd ed. Washington, DC: APA; 2010.
-
- Leucht S., Arbter D., Engel R., Kissling W., Davis J. How effective are second-generation antipsychotic drugs? Mol. Psychiatry. 2009;14:429–447. - PubMed
-
- Lepping P., Sambhi R., Whittington R., Lane S., Poole R. Clinical relevance of findings in trials of antipsychotics: Systematic review. Br. J. Psychiatry. 2011;198:341–345. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
